Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
International Journal of Cardiology
|
February 11, 2015
The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients
Lok B Yap, Faisal Qadir, Son T B Nguyen, et al.
ERJ Open Research
|
October 27, 2022
Prevalence and genetic basis of first-line drug resistance of <i>Mycobacterium tuberculosis</i> in Ca Mau, Vietnam
Jack Callum, Phuong T B Nguyen, Elena Martinez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2016
Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant
Rongsheng E Wang, Ying Wang, Yuhan Zhang, et al.
Cell Metabolism
|
February 11, 2025
Lactate controls cancer stemness and plasticity through epigenetic regulation
Nguyen T B Nguyen, Sira Gevers, Rutger N U Kok, et al.
Journal of the American Chemical Society
|
June 9, 2025
Cobalt-Catalyzed Enantioconvergent Decarboxylative N-Alkylation
Siwen Huang, Ramon Trevino, Dishun Zuo, et al.
Public Health Action
|
September 22, 2023
Tuberculin skin testing and QuantiFERON™-TB Gold Plus positivity among household contacts in Vietnam
A L Innes, S T Nguyen, V Lebrun, et al.
The New England Journal of Medicine
|
October 3, 2019
Community-wide Screening for Tuberculosis in a High-Prevalence Setting
Guy B Marks, Nhung V Nguyen, Phuong T B Nguyen, et al.
European Review for Medical and Pharmacological Sciences
|
April 1, 2022
Diagnostic value of cerebral vasospasm by transcranial doppler ultrasound in Vietnamese patients with subarachnoid hemorrhage
H-K Vo, V-T Le, V-L Nguyen, et al.
Journal of Medicinal Chemistry
|
February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead
N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Journal of Medicinal Chemistry
|
June 14, 2024
Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead"
N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
International Journal of Cardiology
|
February 11, 2015
The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients
Lok B Yap, Faisal Qadir, Son T B Nguyen, et al.
ERJ Open Research
|
October 27, 2022
Prevalence and genetic basis of first-line drug resistance of <i>Mycobacterium tuberculosis</i> in Ca Mau, Vietnam
Jack Callum, Phuong T B Nguyen, Elena Martinez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2016
Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant
Rongsheng E Wang, Ying Wang, Yuhan Zhang, et al.
Cell Metabolism
|
February 11, 2025
Lactate controls cancer stemness and plasticity through epigenetic regulation
Nguyen T B Nguyen, Sira Gevers, Rutger N U Kok, et al.
Journal of the American Chemical Society
|
June 9, 2025
Cobalt-Catalyzed Enantioconvergent Decarboxylative N-Alkylation
Siwen Huang, Ramon Trevino, Dishun Zuo, et al.
Public Health Action
|
September 22, 2023
Tuberculin skin testing and QuantiFERON™-TB Gold Plus positivity among household contacts in Vietnam
A L Innes, S T Nguyen, V Lebrun, et al.
The New England Journal of Medicine
|
October 3, 2019
Community-wide Screening for Tuberculosis in a High-Prevalence Setting
Guy B Marks, Nhung V Nguyen, Phuong T B Nguyen, et al.
European Review for Medical and Pharmacological Sciences
|
April 1, 2022
Diagnostic value of cerebral vasospasm by transcranial doppler ultrasound in Vietnamese patients with subarachnoid hemorrhage
H-K Vo, V-T Le, V-L Nguyen, et al.
Journal of Medicinal Chemistry
|
February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead
N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Journal of Medicinal Chemistry
|
June 14, 2024
Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead"
N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Page
of 13